What would you change US stock market hours to if you could & why? (long on thoughtfulness please, funny is an option, keep puns short)
Here’s another thought. How about introducing newly public companies to market by starting with short trading hours, 3 days a week & then opening up to standard hours after 1-2 years?
What would be ideal public exchange hours from the standpoint of emerging biotech companies (consider their needs) and the funds that provide most of their backing?
Results would prob look different if we polled executives of newly public biotechs & their major backers. They need markets for financings & some liquidity for employees. Major holders trade in blocks. Fewer trading days, shorter hours would get it done w/less distraction.
The markets, as they exist now, serve traders & represent a compromised existence for companies looking for a broader set of investors. Would be cool if there were a Nasdaq-lite market. I think biotech would be more productive... & each open day more special for its traders.

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Peter Kolchinsky

Peter Kolchinsky Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @PeterKolchinsky

24 Oct
Once covid vaccines launch, we might trick ourselves into believing they cause everything from colorectal cancer to diabetes to heart disease & lupus. Well-meaning data miners could do real harm. We need to vaccinate ourselves against that. Here’s how. 1/
Consider that many people have avoided going to the doctor for regular checkups during covid. They haven’t gotten preventative care. They haven’t been diagnosed with emergent conditions. They might now have heart disease or cancer and not yet know it. 2/
Here’s a paper showing that cancer diagnoses have gone down during covid. They say “The delay in diagnosis will likely lead to presentation at more advanced stages and poorer clinical outcomes.“ jamanetwork.com/journals/jaman… 3/
Read 20 tweets
16 Oct
Delays in FDA approval of a vaccine probably won’t change when most of us get a vaccine. PFE says it might be able to seek approval by end of Nov, so Dec approval possible. But will only have 100M doses ready by YE (50M courses). So unless you have... nytimes.com/2020/10/16/hea…
So unless you have reason to think you would be among the 50M first up to get vaccinated, what will determine when you get vaccinated is the pace of production. & for most of us, our ticket likely won’t be called until 2Q21. So approval delays of 1-2 months won’t change that.
You might even prefer that the vaccines be vetted more carefully. Of course, the people who would be impacted by delays are those slated to get the first doses. Front-line workers, vulnerable. They too might prefer to know the vaccines are safe and effective.
Read 6 tweets
29 Sep
It seems @icer_review’s heart is showing a little in today’s report on essential compassion & fairness of proper insurance w/ low OOP costs for medicines. But they still have a lingering attachment to math that’s been rightly criticized as racist... icer-review.org/wp-content/upl… 1/
...by patient advocate @SuePeschin in this short, incisive piece. morningconsult.com/opinions/cost-… I wonder if it’s a bit uncomfortable for policymakers ICER claims to have influenced w/ its math. After all, #badmathkills 2/
.@icer_review says if medicines for kids w/ sickle cell disease don’t make the cut according to their math (which @SuePeschin has pointed out is deeply flawed), insurance should make those meds unaffordable to them (w/ high OOP costs) as leverage over drug companies. Harsh.
Read 9 tweets
30 Aug
No viruses in this one but it’s still fun. In the spirit of the enemy of my enemy, there was once a time when MALARIA was a dangerous friend worth having in the fight against a deadlier pathogen: SYPHILIS. Like Godzilla vs Mothra, doctors would infect patients dying... Image
...from syphilis w/ malaria to cause them to spike a raging fever. Syphilis is a really nasty bacteria that for millennia was considered incurable, though patients could recover if their had a high enough fever... esp on Saturdays. Image
Malaria was hardly a walk in the park & one might not consider trading malaria for syphilis to be medically ethical, except that there was a drug, quinine, for malaria. So idea was to cure syphilis w/ malaria & cure malaria w/ quinine. Fun fact: quinine glows in black light: Image
Read 8 tweets
28 Aug
With each new drug, patients w/ lung cancer live longer. If first one hadn’t been rewarded, all rest wouldn’t have followed. Only insurance makes all affordable. Eventually they go generic; society saves money & humanity forever enjoys longer life span. Biotech Social Contract! Image
Flagging here for a few thought leaders in or soon to be Washington as they consider how healthcare should work. @Tcardenas @ngoroff @StefFeldman @JoeBiden
Here’s the whole paper, from folks at FDA, who are fortunate to see the totality of the constant effort to push back against the threat of disease that weighs upon us all. ascopubs.org/doi/full/10.12…
Read 4 tweets
26 Aug
For RA Capital’s next Business of Biotech course, I could use some advice. Do students learn as effectively listening to an audiobook as when they read the actual book? If you’ve taught and grappled with this, please add your comments.
I’m thrilled that thegreatamericandrugdeal.com is available as an Audiobook, though I’m wondering whether old school is better for teaching.
Internet is filled with advice. Here’s a thoughtful piece. But lately I’ve been getting all my peer-reviewed scientific analysis from twitter so figured I would come back for more. psychologytoday.com/us/blog/friend…
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!